Tri-Ponderal Mass Index vs. Fat Mass/Height3 as a Screening Tool for Metabolic Syndrome Prediction in Colombian Children and Young People
Metadatos
Mostrar el registro completo del ítemAutor
Ramírez-Vélez, Robinson; Correa-Bautista, Jorge Enrique; Carrillo, Hugo Alejandro; González Jiménez, Emilio; Schmidt Río Valle, Jacqueline; Correa Rodríguez, María; García-Hermoso, Antonio; González-Ruiz, KatherineEditorial
MDPI
Materia
Adiposity Fat mass Tri-ponderal mass index Fat mass index Metabolic syndrome Children
Fecha
2018-03-27Referencia bibliográfica
Ramírez-Vélez, R. [et al.]. Tri-Ponderal Mass Index vs. Fat Mass/Height3 as a Screening Tool for Metabolic Syndrome Prediction in Colombian Children and Young People. Nutrients 2018, 10, 412. [http://hdl.handle.net/10481/54899]
Patrocinador
This study was part of the project entitled “Body Adiposity Index and Biomarkers of Endothelial and Cardiovascular Health in Adults”, which was funded by the Centre for Studies on Measurement of Physical Activity, School of Medicine and Health Sciences, Universidad del Rosario (Code N FIUR DN-BG001), and the “FUPRECOL Study” was possible given the financial support provided by the Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología “Francisco José de Caldas” COLCIENCIAS (Contract Number 671-2014 Code 122265743978). The funder had no role in the study design, data collection, data analysis and interpretation, the preparation of the manuscript, or the decision to publish.Resumen
Tri-ponderal mass index (TMI) and fat mass index (FMI) have been proposed as alternative
approaches for assessing body fat since BMI does not ensure an accurate screening for obesity
and overweight status in children and adolescents. This study proposes thresholds of the TMI
and FMI for the prediction of metabolic syndrome (MetS) in children and young people. For this
purpose, a cross-sectional study was conducted on 4673 participants (57.1% females), who were
9–25 years of age. As part of the study, measurements of the subjects’ weight, waist circumference,
serum lipid indices, blood pressure and fasting plasma glucose were taken. Body composition was
measured by bioelectrical impedance analysis (BIA). The TMI and FMI were calculated as weight
(kg)/height (m3) and fat mass (kg)/height (m3), respectively. Following the International Diabetes
Federation (IDF) definition, MetS is defined as including three or more metabolic abnormalities.
Cohort-specific thresholds were established to identify Colombian children and young people at high
risk of MetS. The thresholds were applied to the following groups: (i) a cohort of children where the
girls’ TMI ≥ 12.13 kg/m3 and the boys’ TMI ≥ 12.10 kg/m3; (ii) a cohort of adolescents where the
girls’ TMI ≥ 12.48 kg/m3 and the boys’ TMI ≥ 11.19 kg/m3; (iii) a cohort of young adults where the
women’s TMI ≥ 13.21 kg/m3 and the men’s TMI ≥ 12.19 kg/m3. The FMI reference cut-off values
used for the different groups were as follows: (i) a cohort of children where the girls’ FMI ≥ 2.59
fat mass/m3 and the boys’ FMI ≥ 1.98 fat mass/m3; (ii) a cohort of adolescents where the girls’
FMI ≥ 3.12 fat mass/m3 and the boys’ FMI ≥ 1.46 fat mass/m3; (iii) a cohort of adults where the
women’s FMI ≥ 3.27 kg/m3 and the men’s FMI ≥ 1.65 kg/m3. Our results showed that the FMI
and TMI had a moderate discriminatory power to detect MetS in Colombian children, adolescents,
and young adults.